基因特异性急性巨核细胞白血病在低低二倍倍型B型淋巴细胞白血病之后,由TP53突变联系在一起
Jaryse C Harris1, Jeffrey Schubert2, Brian Lockhart3
1Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
概括
一名患者在B-淋巴细胞白血病 (B-ALL) 后发展出具有巨核细胞分化 (AMKL) 的急性髓性白血病. 基因分析显示,不同的白血病共享TP53突变,强调需要密切监测TP53突变瘤.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
背景情况:
- 巨核细胞分化的急性髓性白血病 (AMKL) 是一种罕见的亚型.
- 低低倍积分的B型淋巴细胞白血病 (B-ALL) 是儿童白血病的一种侵袭性形式.
- 在细胞毒性治疗后可能出现与治疗相关的骨髓状瘤.
研究的目的:
- 在单个患者中调查初始B-ALL和随后的AMKL之间的关系.
- 为了确定两种不同类型的白血病的遗传起源.
- 评估TP53突变在多重骨髓层病变的发展中的作用.
主要方法:
- 下一代测序 (NGS) 用于基因突变分析.
- 比较基因组杂交 (CGH) 或类似的技术来评估遗传变化.
- 审查患者的治疗史和临床过程.
主要成果:
- 患者最初提出的B-ALL具有较低的低分位症.
- 随后对AMKL进行了诊断,AMKL在遗传上与B-ALL.不同.
- 两种白血病类型都含有相同的TP53突变,生殖系检测呈阴性.
结论:
- AMKL不是B-ALL的表型变化,也不是与治疗相关的骨髓瘤.
- 共同的TP53突变表明,要么是受组织限制的宪法突变,要么是血液构造前体的体质突变.
- 这一案例强调了对TP53-突变瘤患者的警监测的重要性,因为他们可能患上多重病变的风险.
更多相关视频
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
13.9K
11:15Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
24.3K
相关概念视频
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
The Intrinsic Apoptotic Pathway
6.2K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.2K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
